Evidence map›Paper›PMID 26306996›Full record

Trial reportInfection control and hospital epidemiology2015

A Randomized Clinical Trial Comparing Use of Rapid Molecular Testing for Staphylococcus aureus for Patients With Cutaneous Abscesses in the Emergency Department With Standard of Care.

Larissa S May, Richard E Rothman, Loren G Miller, Gillian Brooks, Mark Zocchi, Catherine Zatorski, Andrea F Dugas, Chelsea E Ware, Jeanne A Jordan

Registry-linked trialOpen access · greenAbstract readMulticenter StudyRandomized Controlled Trial
In one paragraph

Trial report in Infection control and hospital epidemiology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT01523899 (A Randomized Clinical Trial Comparing Use of Rapid Molecular Testing for Staphylococcus Aureus for Patients With Cutaneous Abscesses in the Emergency Department With Standard of Care.), which is not on this map. Cited by 12 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed, 1 pooled it
1.2field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT01523899 nacompletednot on this map

A Randomized Clinical Trial Comparing Use of Rapid Molecular Testing for Staphylococcus Aureus for Patients With Cutaneous Abscesses in the Emergency Department With Standard of Care.

TypeinterventionalSponsorGeorge Washington UniversityRan2011 to 2015Enrolled252ConditionsCutaneous AbscessArmsXpert MRSA/SA SSTI, Standard culture
3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 1 synthesis or guideline pooled it, 23 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Methicillin-Resistant and Methicillin-SensitiveOpen forum infectious diseases · 2022
    Article
  6. Rapid Detection of Methicillin-ResistantDiagnostics (Basel, Switzerland) · 2020
    Review
  7. Review
  8. Article
  9. Article
  10. Antimicrobial Stewardship in the Emergency Department.Emergency medicine clinics of North America · 2018
    Review
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Larissa S May1Emergency Department Antibiotic Stewardship,Department of Emergency Medicine,University of California-Davis,Sacramento,California.
Richard E Rothman2Department of Emergency Medicine,Johns Hopkins University,Baltimore,Maryland.
Loren G Miller3Los Angeles BioMedical Research Center at Harbor-UCLA Medical Center,Torrance,California.
Gillian Brooks4Department of Emergency Medicine,George Washington University,Washington,DC.
Mark Zocchi5Office for Clinical Practice Innovation,George Washington University,Washington,DC.
Catherine Zatorski4Department of Emergency Medicine,George Washington University,Washington,DC.
Andrea F Dugas3Los Angeles BioMedical Research Center at Harbor-UCLA Medical Center,Torrance,California.
Chelsea E Ware4Department of Emergency Medicine,George Washington University,Washington,DC.
Jeanne A Jordan6Department of Epidemiology and Biostatistics,School of Public Health,George Washington University,Washington,DC.
George Washington University · US

Funding

Clinical and Translational Science Institute at Children's NationalUL1TR000075 · NCATS · CHILDREN'S RESEARCH INSTITUTE · PI GUAY-WOODFORD, LISA MARIE · 2012 to 2015
$13.7M
CTSA INFRASTRUCTURE FOR PEDIATRIC RESEARCHUL1RR031988 · NCRR · CHILDREN'S RESEARCH INSTITUTE · PI GUAY-WOODFORD, LISA MARIE · 2010 to 2011
$8.2M
Clinical and Translational Science Institute at Children's NationalKL2TR000076 · NCATS · CHILDREN'S RESEARCH INSTITUTE · PI GUAY-WOODFORD, LISA MARIE · 2012 to 2014
$756k
Clinical and Translational Science Institute at Children's NationalKL2RR031987 · NCRR · CHILDREN'S RESEARCH INSTITUTE · PI GUAY-WOODFORD, LISA MARIE · 2010 to 2011
$425k
NCATS NIH HHS KL2 TR000076NCATS NIH HHS UL1 TR000075NCRR NIH HHS KL2 RR031987NCRR NIH HHS KL2RR031987/KL2TR000076NCRR NIH HHS UL1 RR031988NCRR NIH HHS UL1RR031988/UL1TR000075NIAID NIH HHS L30 AI107906
6 · The paper itself

Abstract

objectiveTo determine whether real-time availability of rapid molecular results of Staphylococcus aureus would impact emergency department clinician antimicrobial selection for adults with cutaneous abscesses.

designWe performed a prospective, randomized controlled trial comparing a rapid molecular test with standard of care culture-based testing. Follow-up telephone calls were made at between 2 and 7 days, 1 month, and 3 months after discharge.

settingTwo urban, academic emergency departments. PATIENTS: Patients at least 18 years old presenting with a chief complaint of abscess, cellulitis, or insect bite and receiving incision and drainage were eligible. Seven hundred seventy-eight people were assessed for eligibility and 252 met eligibility criteria.

methodsClinician antibiotic selection and clinical outcomes were evaluated. An ad hoc outcome of test performance was performed.

resultsWe enrolled 252 patients and 126 were randomized to receive the rapid test. Methicillin-susceptible S. aureus-positive patients receiving rapid test results were prescribed beta-lactams more often than controls (absolute difference, 14.5% [95% CI, 1.1%-30.1%]) whereas methicillin-resistant S. aureus-positive patients receiving rapid test results were more often prescribed anti-methicillin-resistant S. aureus antibiotics (absolute difference, 21.5% [95% CI, 10.1%-33.0%]). There were no significant differences between the 2 groups in 1-week or 3-month clinical outcomes.

conclusionAvailability of rapid molecular test results after incision and drainage was associated with more-targeted antibiotic selection. TRIAL REGISTRATION clinicaltrials.gov Identifier: NCT01523899.

Indexed as

AbscessAcademic Medical CentersAdultAgedAnti-Bacterial AgentsBaltimorebeta-LactamsDistrict of ColumbiaEmergency Service, HospitalFemaleHumansMaleMethicillin-Resistant Staphylococcus aureusMiddle AgedProspective StudiesStandard of CareAnti-Bacterial Agentsbeta-Lactams

Identifiers

PMID26306996
PMCPMC5336348
OpenAlexW1923289310

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.